
Protinash Therapeutics Private Limited
About Protinash Therapeutics Private Limited
Data last updated:
Protinash Therapeutics Private Limited was a private limited company based in Secunderabad, Telangana, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the scientific research segment of the research and development sector. It was incorporated on 16 August 2019.
The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U73100TG2019PTC134829. Its GSTIN is 36AAKCP7233K1Z0 (Telangana).
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Hormuzd Rayomand Mulla and Hemant Vasant Joshi.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office was at B 807 Necklace Pride Kavadiguda Main Road, Secunderabad, Telangana, India – 500003.
Company details
Contact details
Protinash Therapeutics Private Limited's registered office is in Secunderabad, Telangana. Its e-mail address is in the company report.
- Email
- Registered AddressB 807 Necklace Pride Kavadiguda Main Road, Secunderabad, Telangana, India – 500003
- IndustryResearch & Development, Science Research
To see the full contact details of Protinash Therapeutics Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Protinash Therapeutics Private Limited
FY 2023 filings availableFinancial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | |||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | |||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | |||
| Net Profit Margin | |||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Protinash Therapeutics Private Limited, buy the company report.
Board of directors of Protinash Therapeutics Private Limited
Protinash Therapeutics has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hormuzd Rayomand Mulla | Director | 16 Aug 2019 | 7 Years 2 Months | As last reported |
| Hemant Vasant Joshi | Director | 16 Aug 2019 | 7 Years 2 Months | As last reported |
Legal cases
No court or tribunal cases involving Protinash Therapeutics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Protinash Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Protinash Therapeutics has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAKCP7233K1Z0 | Telangana | Active | 26 Nov 2019 |
To see the full GST registrations and return filing status of Protinash Therapeutics Private Limited, buy the company report.
Recent activity
Protinash Therapeutics Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Hemant Vasant Joshi was appointed as Director on 16 Aug 2019.
Frequently asked questions
Protinash Therapeutics has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Protinash Therapeutics was a private limited company based in Secunderabad, Telangana, India. The company worked in science research, within the research and development industry. It was incorporated on 16 August 2019 and is registered under CIN U73100TG2019PTC134829. The company has been struck off by the Registrar of Companies and is no longer operational.
Protinash Therapeutics had 2 directors:
- Hormuzd Rayomand Mulla - Director
- Hemant Vasant Joshi - Director
The CIN (Corporate Identification Number) of Protinash Therapeutics is U73100TG2019PTC134829. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Protinash Therapeutics is at B 807 Necklace Pride Kavadiguda Main Road, Secunderabad, Telangana, India – 500003.
Protinash Therapeutics was incorporated on 16 August 2019. It is registered with the Registrar of Companies, Hyderabad.
The latest financial statements of Protinash Therapeutics on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Protinash Therapeutics is 36AAKCP7233K1Z0, registered in Telangana.
Protinash Therapeutics operated in the research and development industry, in the science research segment. It worked in this industry before it was struck off.
Hemant Vasant Joshi was appointed as Director on 16 Aug 2019. Hormuzd Rayomand Mulla was appointed as Director on 16 Aug 2019.